Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)
Turkey · Delayed Price · Currency is TRY 5.83
+0.02 (0.34%)
At close: Oct 28, 2026
IST:ANGEN Ratios and Metrics
Market cap in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,283 | 2,378 | 2,719 | 2,739 | 4,741 | 3,212 | |
Market Cap Growth | -49.96% | -12.54% | -0.72% | -42.23% | 47.60% | - |
Enterprise Value | 1,760 | 2,422 | 2,453 | 2,393 | 4,339 | - |
Last Close Price | 5.83 | 10.81 | 12.36 | 12.45 | 20.53 | 12.73 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | - | 7.41 |
PS Ratio | 1.72 | 3.22 | 3.92 | 7.96 | 10.12 | 7.83 |
PB Ratio | 0.71 | 1.37 | 1.34 | 1.56 | 3.15 | 3.89 |
P/TBV Ratio | 0.71 | 1.37 | 1.38 | 1.64 | 3.20 | 4.24 |
P/FCF Ratio | - | - | - | 7.88 | 9.55 | 9.74 |
P/OCF Ratio | 3.96 | 9.52 | 14.69 | 6.45 | 7.95 | 7.89 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.36 | 3.28 | 3.54 | 6.96 | 9.26 | - |
EV/EBITDA Ratio | 100.36 | 31.01 | 16.50 | 45.06 | 13.10 | - |
EV/EBIT Ratio | - | - | 107.93 | - | 15.83 | - |
EV/FCF Ratio | - | - | - | 6.89 | 8.74 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.31 | 0.17 | 0.01 | 0.02 | 0.02 | 0.01 |
Debt / EBITDA Ratio | 32.03 | 3.71 | 0.17 | 0.65 | 0.07 | 0.01 |
Debt / FCF Ratio | - | - | - | 0.10 | 0.04 | 0.01 |
Net Debt / Equity Ratio | 0.27 | 0.11 | -0.13 | -0.28 | -0.42 | -0.62 |
Net Debt / EBITDA Ratio | 29.64 | 2.47 | -1.78 | -9.13 | -1.91 | -1.60 |
Net Debt / FCF Ratio | -6.40 | -1.04 | 1.92 | -1.39 | -1.27 | -1.55 |
Asset Turnover | 0.32 | 0.32 | 0.32 | 0.19 | 0.37 | 0.65 |
Inventory Turnover | 0.93 | 0.66 | 0.64 | 0.22 | 0.37 | 0.93 |
Quick Ratio | 0.90 | 1.25 | 3.88 | 10.07 | 29.08 | 22.12 |
Current Ratio | 2.02 | 2.82 | 8.66 | 15.70 | 41.91 | 25.28 |
Return on Equity (ROE) | -15.00% | -16.60% | -15.15% | -12.11% | -0.86% | 76.33% |
Return on Assets (ROA) | -2.76% | -1.41% | 0.66% | -0.79% | 13.66% | 30.72% |
Return on Invested Capital (ROIC) | -4.73% | -2.87% | 1.50% | -2.14% | -10.11% | 108.40% |
Return on Capital Employed (ROCE) | -4.40% | -2.50% | 1.00% | -1.20% | 16.90% | 37.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -20.15% | -13.15% | -10.54% | -7.20% | -0.44% | 13.49% |
FCF Yield | -5.81% | -7.83% | -5.06% | 12.68% | 10.47% | 10.27% |
Dividend Yield | 10.22% | - | - | - | 2.77% | - |
Payout Ratio | - | - | - | - | - | 48.46% |
Buyback Yield / Dilution | - | - | - | - | -45.28% | - |
Total Shareholder Return | 10.22% | - | - | - | -42.52% | - |